Search

everythinglearnresearchcommunity

for

Search:↓

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Current treatments for alopecia show no significant long-term benefits.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Early skin biopsy helps diagnose and manage severe skin conditions in babies.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Stress can stop hair growth in mice, and treatments can reverse this effect.